nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An INDEPTH look at global data collection
|
The Lancet Diabetes & Endocrinology, |
|
2015 |
3 |
12 |
p. 915- 1 p. |
artikel |
2 |
Correction to Lancet Diabetes Endocrinol 2015; 3: 855–65
|
|
|
2015 |
3 |
12 |
p. e11- 1 p. |
artikel |
3 |
Correction to Lancet Diabetes Endocrinol 2015; 3: 921–23
|
|
|
2015 |
3 |
12 |
p. e11- 1 p. |
artikel |
4 |
Effect of low-fat diet interventions versus other diet interventions on long-term weight change in adults: a systematic review and meta-analysis
|
Tobias, Deirdre K |
|
2015 |
3 |
12 |
p. 968-979 12 p. |
artikel |
5 |
Endocrine-disrupting chemicals and the diabetes epidemic in countries in the WHO South-East Asia region
|
Gifford, Robert |
|
2015 |
3 |
12 |
p. 925-927 3 p. |
artikel |
6 |
Is the artificial pancreas coming to a home near you?
|
Legault, Laurent |
|
2015 |
3 |
12 |
p. 916-917 2 p. |
artikel |
7 |
Mobile applications for diabetes management: efficacy issues and regulatory challenges
|
Istepanian, Robert S H |
|
2015 |
3 |
12 |
p. 921-923 3 p. |
artikel |
8 |
2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial
|
Kropff, Jort |
|
2015 |
3 |
12 |
p. 939-947 9 p. |
artikel |
9 |
Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial
|
Becker, Clemens |
|
2015 |
3 |
12 |
p. 948-957 10 p. |
artikel |
10 |
Myostatin inhibition for treatment of sarcopenia
|
Parise, Gianni |
|
2015 |
3 |
12 |
p. 917-918 2 p. |
artikel |
11 |
Non-linear association between smoking cessation and incident type 2 diabetes
|
Pham, Ngoc Minh |
|
2015 |
3 |
12 |
p. 932- 1 p. |
artikel |
12 |
Of rats and men: thyroid homeostasis in rodents and human beings
|
Dietrich, Johannes W |
|
2015 |
3 |
12 |
p. 932-933 2 p. |
artikel |
13 |
Of rats and men: thyroid homeostasis in rodents and human beings – Authors' reply
|
McAninch, Elizabeth A |
|
2015 |
3 |
12 |
p. 933- 1 p. |
artikel |
14 |
Prescribing low-fat diets: useless for long-term weight loss?
|
Hall, Kevin D |
|
2015 |
3 |
12 |
p. 920-921 2 p. |
artikel |
15 |
Preventing cardiovascular events with empagliflozin: at what cost?
|
Naci, Huseyin |
|
2015 |
3 |
12 |
p. 931- 1 p. |
artikel |
16 |
Reduction of cardiovascular risk in chronic kidney disease by mineralocorticoid receptor antagonism
|
Epstein, Murray |
|
2015 |
3 |
12 |
p. 993-1003 11 p. |
artikel |
17 |
Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis
|
Pan, An |
|
2015 |
3 |
12 |
p. 958-967 10 p. |
artikel |
18 |
Research in Brief
|
Kang, Seema |
|
2015 |
3 |
12 |
p. 934- 1 p. |
artikel |
19 |
Smoking and diabetes risk: building a causal case with clinical implications
|
Sattar, Naveed |
|
2015 |
3 |
12 |
p. 918-920 3 p. |
artikel |
20 |
Sustainable financing: the Achilles heel of the non-communicable diseases response
|
Dain, Katie |
|
2015 |
3 |
12 |
p. 923-925 3 p. |
artikel |
21 |
Testosterone in women—the clinical significance
|
Davis, Susan R |
|
2015 |
3 |
12 |
p. 980-992 13 p. |
artikel |
22 |
The artificial pancreas: challenges and opportunities
|
Farrington, Conor |
|
2015 |
3 |
12 |
p. 937- 1 p. |
artikel |
23 |
Turning big data into personalised diabetes care
|
Mohammadi, Dara |
|
2015 |
3 |
12 |
p. 935-936 2 p. |
artikel |
24 |
Type 2 diabetes in migrant south Asians: mechanisms, mitigation, and management
|
Sattar, Naveed |
|
2015 |
3 |
12 |
p. 1004-1016 13 p. |
artikel |
25 |
Understanding EMPA-REG OUTCOME
|
Ceriello, Antonio |
|
2015 |
3 |
12 |
p. 929-930 2 p. |
artikel |
26 |
Understanding EMPA-REG OUTCOME
|
Muskiet, Marcel H A |
|
2015 |
3 |
12 |
p. 928-929 2 p. |
artikel |
27 |
Understanding EMPA-REG OUTCOME
|
Gilbert, Richard E |
|
2015 |
3 |
12 |
p. 930-931 2 p. |
artikel |
28 |
Weiping Jia: researching diabetes with Chinese characteristics
|
Ouyang, Yadan |
|
2015 |
3 |
12 |
p. 938- 1 p. |
artikel |